Covered recipient · General Payments record
HARSHITA R PARIPATI
Allopathic & Osteopathic Physicians Internal Medicine Medical Oncology
General Payments · PY2018–2023
$7,952.98
- Reported across 358 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Education | $199.98 | 2 |
| Food and Beverage | $171.36 | 7 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $199.98 | 2 |
| Celgene Corporation | $52.10 | 2 |
| Pharmacyclics LLC, An AbbVie Company | $34.62 | 1 |
| Janssen Biotech, Inc. | $29.47 | 1 |
| EISAI INC. | $20.38 | 1 |
| GENZYME CORPORATION | $19.64 | 1 |
| ARRAY BIOPHARMA INC | $15.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ARRAY BIOPHARMA INC | $15.15 | 01/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050311199 | CMS |
| AstraZeneca Pharmaceuticals LP | $99.99 | 01/09/2023 | Education | Undisputed | 01/23/2026 | 1014621815 | CMS |
| AstraZeneca Pharmaceuticals LP | $99.99 | 04/04/2023 | Education | Undisputed | 01/23/2026 | 1011976127 | CMS |
| Celgene Corporation | $19.87 | 01/03/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016199191 | CMS |
| Celgene Corporation | $32.23 | 02/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1016199221 | CMS |
| Eisai Inc. | $20.38 | 01/04/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023312235 | CMS |
| GENZYME CORPORATION | $19.64 | 01/06/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1050036683 | CMS |
| Janssen Biotech, Inc. | $29.47 | 01/07/2023 | Food and Beverage | Undisputed | 01/23/2026 | 988079625 | CMS |
| Pharmacyclics LLC, An AbbVie Company | $34.62 | 01/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 998292385 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.